Business Context and Reporting Period
This Form 8-K Current Report was filed by CARMAX, INC. on December 23, 2005. The filing addresses a material definitive agreement regarding executive compensation adjustments for President and Chief Executive Officer Austin Ligon, who announced his retirement for calendar year 2006.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a specific executive compensation agreement and does not contain general financial performance data.
Material Changes and Executive Compensation
- New Option Grant: On December 23, 2005, the Company granted Mr. Ligon options to purchase 199,481 shares of common stock at an exercise price of $28.26 per share.
- Vesting Schedule: 25% of the new options vest on each of the first four anniversaries of the grant date. The term is eight and a half years.
- Correction of Prior Terms: The Company discovered that incentive award agreements for fiscal years 2005 and 2006 (Prior Option Grants) contained an unintended term requiring vested options to be exercised within three months of retirement. The new grant corrects this to align with fiscal year 2004 terms, allowing vested options to be exercisable until the expiration date of the grant upon retirement, death, or disability.
- Unvested Options: All unvested options under the new grant, prior grants, and fiscal year 2004 grants immediately vest upon termination due to retirement, death, or disability.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or general risk factors. The primary contingency noted is the correction of the exercise period for Mr. Ligon's prior option grants to ensure they reflect the Company's original intent regarding retirement benefits. The Prior Option Grants remain effective and are not altered by this new grant.
Investor Verification Checklist
- Verify the total number of shares subject to the new option grant (199,481) and the exercise price ($28.26).
- Confirm the specific vesting schedule (25% annually over four years) and the eight-and-a-half-year term.
- Review the attached Exhibit 10.1 (Form of Incentive Award Agreement) for complete legal terms.
- Understand that this grant is a remedial measure to fix unintended restrictions in prior fiscal year grants regarding the post-retirement exercise window.